The Vanguard Group Discloses Interests in PureTech Health

The Vanguard Group, Inc. has disclosed its position in PureTech Health plc according to Rule 8.3 of the Takeover Code. This disclosure reports that Vanguard holds a significant interest representing 3.95% of the relevant securities in PureTech Health plc as of April 7, 2025.

The disclosure provides detailed information about the relevant securities owned, totaling 9,476,147 1p ordinary shares. No positions in cash-settled or stock-settled derivatives were reported. Additionally, there are no agreements, arrangements, or understandings relating to options or derivatives.

The disclosure confirms that The Vanguard Group has not engaged in any other dealings concerning PureTech Health securities, nor are there any indemnity or other dealing arrangements in place. No supplemental forms regarding open positions are attached.